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Abstract
Purpose The aim was to compare late-time extrapolation of
plasma clearance (CL) from Tikhonov adaptively regular-
ized gamma variate fitting (Tk-GV) and from mono-
exponential (E1) fitting.
Methods Ten
51Cr-ethylenediaminetetraacetic acid bolus IV
studies in adults—8 with ascites—assessed for liver
transplantation, with 12–16 plasma samples drawn from
5 - m i nt o2 4 - h ,w e r ef i tw i t hT k - G V a n dE 1m o d e l sa n d
CL results were compared using Passing-Bablok fitting.
Results The 24-h CL(Tk-GV) values ranged from 11.4 to
79.7 ml/min. Linear regression of 4- versus 24-h CL(Tk-GV)
yielded no significant departure from a slope of 1, whereas
the 4- versus 24-h CL(E1) slope, 1.56, was significantly
increased. For CL(Tk-GV-24-h) versus CL(E1-24-h), there
was a biased slope and intercept (0.85, 5.97 ml/min).
Moreover, the quality of fitting of 24-h data was significantly
better for Tk-GV than for E1, as follows. For 10 logarithm of
concentration curves, higher r values were obtained for each
Tk-GV fit (median 0.998) than for its corresponding E1 fit
(median 0.965), with p<0.0001 (paired t-test of z-statistics
from Fisher r-z transformations). The E1 fit quality degraded
with increasing V/W [volume of distribution (l) per kg body
weight, p=0.003]. However, Tk-GV fit quality versus V/W
was uncorrelated (p=0.8).
Conclusion CL(E1) values were dependent on sample time
and the quality of fit was poor and degraded with increasing
ascites, consistent with current opinion that CL(E1) is
contraindicated in ascitic patients. CL(Tk-GV) was rela-
tively more accurate and the good quality of fit was
unaffected by ascites. CL(Tk-GV) was the preferred method
for the accurate calculation of CL and was useful despite
liver failure and ascites.
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Γ Tikhonov matrix [do not confuse with Γ(x)]
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R 1
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is a generalization of the factorial,
ΓðnÞ¼ n   1 ðÞ !
K Constant of proportionality for GV
MRT Mean residence time
<(a) (Psi) digamma function of a is
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sa;sb;sCL SDs of a;b;CL for Tk-GV Eq. 4
sV SD of V from Tk-GV Eq. 5
SD Standard deviation
Tk-GV Tikhonov regularization of GV fit of CVof CL
V Volume of distribution of marker (ml or l)
Introduction
This paper presents a validation of a curve fit method for
measuring plasma clearance (CL, ml/min). The CL method
validated here uses Tikhonov adaptively regularized gamma
variate (Tk-GV) fitting. The word “adaptive” is used to
imply minimization of relative error of CL as opposed to an
ordinary curve fit minimization (Appendix and [13]). In
general, radiometric CL is indicated:
& To detect nephrotoxicity of chemotherapy drugs, especially
in children
& For many chemotherapeutic agents’ dose calculations
& For detection of renal failure in patients in whom (a)
serum creatinine results might be misleading, (b)
missing a decline in renal function might be disastrous
e.g. single kidney, renovascular disease or renal trans-
plant and (c) a 24-h clearance measurement is difficult,
e.g., in the elderly or those with learning difficulties
& For assessment of potential live donors for kidney
transplantation
& For the evaluation and follow-up of chronic renal disease
& For the evaluation of single kidney function in
conjunction with relative renal function measurements
from static or dynamic radionuclide imaging [2]
However, utilization of radiometric CL methods is spotty
with only occasional centres performing them, with needed
but inconsistently applied CL-value correction factors,
without quality control of the individual CL-values, and in
certain cases, current methods are relatively contraindi-
cated. For example, liver failure, ascites, oedema and low
CL are identified in the 2004 British Nuclear Medicine
Society Guidelines as having problematically inaccurate
CL-values [2]. On the other hand, Xirouchakis et al. [14]
outline the clinical importance of CL measurements in liver
failure: “Renal dysfunction is a well-established predictor
of mortality in both acute liver failure and cirrhosis,
particularly following the development of complications,
such as sepsis. Inulin clearance and other direct methods
using injected exogenous radiolabelled substances [
51Cr-
EDTA (ethylenediamine tetra-acetic acid),
125I-Iothalamate,
99mTc-DTPA (diethylenetriamine penta-acetic acid)] are the
most accurate to assess renal function.” Thus, the need for CL
measurements in liver failure is clear, but current radiometric
methods are inadequate for this purpose [2, 4, 6, 8, 9].
In this study, Tk-GV CL values will be obtained for ten
liver failure patients most of whom (8/10) have ascites.
Investigated here is whether the Tk-GV models overcome
the need for CL-value correction factors and maintain good
quality even in the presence of ascites. In prior published
work, the Tk-GV method has been applied to 4-h data using
99mTc-DTPA and
169Yb-DTPA [13]. Tk-GV results provide
quality control for each individual CL-value. The current
paper is a first application of Tk-GV to
51Cr-EDTA data,
and to sampling data extended to 24-h. There is no a priori
guarantee that Tk-GV will either usefully fit an untried
pharmaceutical or 24-h data so testing is needed. The Tk-GV
results are contrasted with those from mono-exponential (E1)
fitting. E1 models fit to this new data are, from prior work,
fairly certain to be problematic [13], especially in ascites
[2, 4, 6, 8, 9]. Thus, how poorly E1 performs for our 24-h
data is also of interest.
Intravenous (IV) bolus-injected inert markers clear into
the interstitium as well as in the urine. Consequently, CL is
slightly faster than glomerular filtration rate (GFR)[ 3, 5,
13], e.g. CL≈1.076 GFR [5]. After IV bolus injection, CL
estimates from multiple plasma samples are calculated from
the area under the plasma marker disappearance curve
(AUC) from time equals zero to infinity, i.e. CL=dose/AUC.
AUC has units of concentration min. and marker (e.g. drug)
systemic exposure time is plasma clearance (CL) related [1,
13]. Even the most minimalistic technique for estimating
AUC, e.g. numerical integration [5], requires the use of a
curve fit to extrapolate concentrations from the time of last
sample to infinite time. In this paper, the E1 and Tk-GV
curve fit methods for finding AUC are tested to determine
the accuracy of CL from curve fitting of 4- versus 24-h data
for ten
51Cr-EDTA concentration curves. A key issue
explored is how well clearances determined only from
4-h data predict the results determined from 24-h data.
When the 4-h CL curve does a good job of predicting the
24-h concentrations, the model extrapolates the late-time
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ances. Conversely, if the 4-h CL curve fits do not predict the
24-h concentrations, then the ability of the fitting procedure
to predict accurately the late-time behaviour is in question
and the clearance values predicted from the method are
suspect.
On a lnE1 versus t plot, lnE1 models are, of course,
straight lines. However, let Cobs(t) be the observed concen-
trations. Then, on a lnCobs(t) versus t plot, the data are
curved; thus E1 models do not fit data well. This same
trend, i.e. curvature, is also seen in a plot of lnCobs(t) versus
lnE1, and the Pearson r-value is less than 1. Indeed, from
lnCobs(t) versus lnE1, the best R
2-value that can be
achieved by a linear fit (i.e. an E1 model of any kind, fit
to any subset of the data) is the Pearson r-value squared, i.e.
r
2, as this is the limitation of the data’s linearity. To achieve
a better fit and to gain better predictability, one needs to use
curves that follow the curvature of the lnCobs(t)v e r s u st plot.
As we shall see, such a curve is the Tk-GV model. If such a
model successfully follows the data’s curvature, the observed
log concentrations, lnCobs(t), will be much better correlated
with the model predictions. In other words, in a plot of
lnCobs(t)v e r s u sl n CTk-GV(t), the relationship should be
almost perfectly linear, unlike the lnCobs(t)v e r s u sl n CE1(t)
plots that show curvature and thus imperfect correlation.
Materials and methods
The patients are part of a research project comparing
methods of assessing renal function in cirrhosis approved
by the Royal Free Hospital Research Ethics Committee.
Thirteen patients with cirrhosis under assessment for liver
transplantation had
51Cr-EDTA bolus IV studies. Of these,
three patients did not have plasma samples drawn at various
times, e.g. at 12- or 24-h, and were discarded. Of the
remaining ten patients, four had hepatitis C-related cirrhosis
(one also with hepatocellular carcinoma), three had alco-
holic cirrhosis, two had primary biliary cirrhosis, and one
had non-alcoholic, fatty liver disease-associated cirrhosis.
Eight were men and two women: eight were white, one
black and one South Asian Indian. The median weight was
79.5 kg (range 51.3–105.8), median serum bilirubin was
66 mmol/l (range 13–390), median serum albumin was
35 g/l (range 26–40) and median INR was 1.7 (range 1.5–
2.4). Hepatic encephalopathy was present in eight and
ascites in eight. The patients had 12–16 plasma samples
drawn from 5-min to 24-h. Their concentration curves were
fit with Tk-GV and E1 models and CL results were
compared using Passing-Bablok fitting and paired (corre-
lated) samples t-tests. A minimum of two samples
determines an E1 solution, and fits to data from 5-min to
4-, 12- and 24-h are examined here. Also examined is a
recommended clinical method of obtaining E1 functions
from plasma samples at 2- and at 4-h [2]. Exponential
models have uniform concentrations (i.e. are well mixed,
aka, instant mixing) in one or more partial volumes. For
Tk-GV fitting, a minimum of four samples are needed. The
GV concentration, C(t), model used for Tk-GV fitting is
GV ¼ CðtÞ¼Kta 1e bt, where C(t) is the marker concen-
tration, a is the dimensionless volume of distribution
scaling factor with V=aCL/b, b is the renal elimination
rate constant, K is a constant, and the mean residence time
MRT=a/b. The Tk-GV method uses least relative error of
CL as a minimization target (see the Appendix) and is more
robust than GV fitting with least-squares regression. The fit
results for well-posed GV CL-values (0<a≤1, b>0, and
fits from 5 or 10 min to at least 3-h of data) are extensively
described elsewhere [13]. In specific, the 0<a≤1 constraint
is only observed with Tk-GV fitting and does not occur
with least-squares GV fitting. A Tk-GV model of an inert
markerisapoorlymixedsystemwithaconcentrationgradient
such that the physical volume of the system is factor of a
times smaller than the virtual volume (where the latter is
CL/b). Moreover, the dynamic equilibrium concentration
gradient is established by renal function and disappears,
i.e. a→1, only when renal function approaches zero [13].
Passing-Bablok fitting is used here for comparison of
methods to provide unbiased linear regression slope and
intercept [7]. The Passing-Bablok method includes the
cusum test for linearity [7], which is useful for comparison
of methods because it detects nonlinear relationships.
Cusum p>0.1 does not suggest nonlinearity, 0.05<p<0.1
suggests nonlinearity, and p<0.05 is highly suggestive of
nonlinearity. Spearman rank correlation is used once for
extracting a correlation in a slightly nonlinear relationship.
Paired (i.e. two, correlated) samples t-testing is used here
for comparison of methods using all the data. Two-sample
t-testing is also applied to (paired) z-statistics from Fisher
r-z transformation for detecting improved correlation. This
transformation changes the otherwise non-normally distrib-
uted correlation coefficients (r) to more normally distribut-
ed z-statistics, using the inverse hyperbolic tangent
function, z=atanh (r). Cobs(t) versus ln(t) plots are used
to explain modelling effects. However, for calculating
model fit quality correlations, we use the logarithm of both
the observed concentrations and the predicted concentra-
tions from the E1 and Tk-GV models. To test how linear the
lnCobs(t) versus lnCModel(t) relationship is, one simply
calculates its Pearson r value. (The correlation coefficient
of determination, R
2, is then the Pearson r-value squared,
i.e. r
2.) The test for ascites looks at the trend of fit quality, r,
versus V/W, where V is the volume of distribution (ml) of
the Tk-GV model, and W is the patient mass in kilograms.
A model r-value that degrades with increasing ascites (as
indexed to V/W) suggests a poorly behaved model. If the
C(t)
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is relatively bulletproof.
Results
Figure 1 shows plots of 24-h concentrations of
51Cr-EDTA
in counts per ml min, C(t), versus the logarithm of time,
t,i nm i n .F i g u r e1 plots show the highest and lowest
CL(Tk-GV) cases (79.7 and 11.4 ml/min) in this series.
These plots suggest an improvement in fit quality for 24-h
data fitsusingTk-GVfunctionscomparedtotheE1functions.
C(t)v e r s u sl n ( t) plots roughly linearize the early-time C(t).
Figure 1 demonstrates that the exponential fit assumption of
a constant concentration at time zero causes underestimation
of the early concentrations of actual data. Let us define late-
time C(t) as being after the concentration curve becomes
nonlinear in ln(t), i.e. asymptotic to the C(t)=0 axis.
Figure 1a demonstrates that when an exponential fit includes
the late-time concentrations, late-time concentrations are
accurately fit. Figure 1b illustrates that when an exponential
fit does not include late-time concentrations, the late-time
concentrations are underestimated.
For several reasons, the correlations (r)u s e df o r
comparison of methods are calculated from the observed
versus predicted logarithms of concentration values. These
r-values (Table 1) are only indirectly related to r-values
calculated without taking logarithms (e.g. the R
2 in
Fig. 1). Comparing methods, the improvement in correlation
to logarithm concentration of lnCobs(t)a n dl n CModel(t)
was highly significant (p<0.0001) for Tk-GV functions
compared to the E1 functions using paired samples
t-testing of the z-values from z=atanh(r). Moreover, the
r-values are better for Tk-GV than for E1 fits in each of
the ten cases (Table 1) .W i t ham e d i a n2 4 - hT k - G Vf i to f
r=0.998, there is little unexplained variance in the
logarithm concentration data models (1−r
2=0.4%). This
gives us confidence that extrapolation from 1,440 min to
infinite time and from 5 min to zero time is accurate. Next,
one uses Tk-GV fits to estimate the percentage of area
under the curve (AUC) of concentration versus time not
directly under the samples. Not surprisingly, there is a
lesser percentage of extrapolated AUC for higher CL (e.g.
Table 1, case 3, 5.4%), and a higher percentage for lower
CL (case 10, 48.3%), and it takes longer than 24-h to clear
51Cr-EDTA in renal failure. However, the goodness of fit
for Tk-GVallows us to have confidence that 24 h of AUC
data is long enough to calculate accurate CL-values. An
indication of CL(Tk-GV) precision is given as standard
deviation (SD) of CL, which values range from 0.4 to 3.5
ml/min in Table 1. The Tk-GV method produces these
estimates during processing. These estimates correspond
to 95% confidence intervals for errors of 24-h CL-values
that range from ±0.8 to ±6.9 ml/min.
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Patient 3, plot of concentration versus logarithm of time.
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Patient 10,  plot of concentration versus logarithm of time.
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(Data)
Data
Tk-GV fit,  R2= 0.991, CL= 11.4 ml/min
E1 fit,       R2 = 0.862, CL= 15.6 ml/min
ab
Fig. 1 a Plot of 24-h concentrations of
51Cr-EDTA in counts per
ml min, C(t), per logarithm of time, t, in min for patient 3’s data. For
patient 3’s 24-h data, R
2(Tk-GV)=0.999>R
2=0.977 from a one
exponential term model (E1). The CL(Tk-GV) for patient 3 is the
highest CL in this series (79.7 ml/min). b Plot of 24-h concentrations,
C(t), per logarithm of time, t, for patient 10’s data, having the lowest
CL(Tk-GV) in this series (11.4 ml/min). Right-hand areas contribute
more to AUC than those on the left do, for this plot type. For example
in b, the AUC for the Tk-GV curve from 1,440 min to infinite time is
47.8% of the total area
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E1 fit equations from any sample subsets have at best a
quality of fit to lnCobs(t) of the correlation coefficient
evaluated at all the sample times (median as r=0.965,
see Table 1). The correlation of r-values from E1 24-h data
fits with V/W (Table 1) is significantly negative,
rrE1 ðÞ ;V=W ½  ¼   0:823, p=0.0034. However, the correla-
tion of r-values from 24-h Tk-GV fits to the data with the
V/W from the same Tk-GV model is uncorrelated,
rrTk‐GV ðÞ ;V=W ½  ¼   0:084, p=0.8165.
Changing sample subsets can produce different CL-
values, especially for E1, as follows. With reference to
Table 2 and Fig. 2a, the 4-h (vertical axis) versus
24-h (horizontal axis) CL(Tk-GV) plot yielded no signifi-
cant Passing-Bablok departure from a line slope of 1 or an
intercept of 0. This means that 4-h Tk-GV clearances
unbiasedly predict 24-h Tk-GV clearances. However, the
R
2-value for this relationship is only 0.738, and the more
powerful paired samples t-test shows a (borderline) signif-
icant bias (p=0.04). This borderline significant mean
difference is 8.6 ml/min greater CL measured for the
4-h data than for the 24-h data. Much of the variance for
predicting 24-h CL from 4-h data is not related to the
method of calculation but to the data themselves, i.e. from
propagation of errors. For example, the furthest 4-h versus
24-h CL(Tk-GV) outlier of Fig. 2a, 64.4 versus 29.9 ml/min,
is only a near outlier at 2.6 interquartile ranges (IQR) and
would not usually require explanation. To decrease the
4- versus 24-h CL(Tk-GV) difference from 11.5 to 3.9 ml/
min (1 SD), one carries the fits out to 12-h (instead of 4-h) of
data when comparing to the 24-h CL. Note (Table 2)t h a tf o r
12- versus 24-h, there is no significant departure from a line
Case CL ±1 SD (ml/min) V ±1 SD (l) V/W (%) AUC of tails (%) Tk-GVr E1 r all fits
3 79.7±0.4 29.7±0.2 34.9 5.4 1.000 0.988
5 76.5±1.6 38.9±1.2 45.2 13.0 0.999 0.933
6 56.5±0.9 21.3±0.6 29.6 6.8 0.998 0.975
9 46.5±0.8 18.6±0.3 22.8 6.9 0.999 0.977
4 45.8±0.8 21.9±0.4 35.6 9.0 0.999 0.971
12 42.5±2.1 26.9±0.9 39.7 13.7 0.995 0.960
13 36.4±3.1 41.9±1.8 39.6 29.3 0.988 0.937
8 29.9±3.5 60.8±4.7 59.9 45.5 0.998 0.848
11 21.2±0.8 17.7±0.4 34.7 19.5 0.998 0.970
10 11.4±0.9 23.4±0.6 30.4 48.3 0.994 0.929
Table 1 From 24-h fitting
to logarithms of concentrations
for Tk-GV , CL and V (l)±1
standard deviation (SD) error,
Vas percent of W (weight-kg),
and percentage of AUC from
extrapolation from left tails
(0 to 5 min) and right tails
(1,440 min to infinite time).
Also shown are correlation
coefficients, r, for Tk-GVand
E1 fitting
Table 2 Tk-GVand E1 line fit tests for slope, m =1, and intercept b=0 and test for significance of different mean values of CL
Passing-Bablok fit lines for Parameter values 95% CI CI R
2
(hr) = 4, 12, 24, 2&4  mb Low to high Significance
Tk-GV(4) = m￿Tk-GV(24) + b [
m 0.971 0.568 to 1.50 NS  ]  0.0416 B  (8.6) 0.738
b 6.7 -15.4 to 28.5 NS 
Tk-GV(12) = m￿Tk-GV(24) + b [
m 0.986 0.795 to 1.15 NS  ]  0.0337 B  (3.1) 0.968
b 3.3 -5.0 to 12.8 NS 
E1(4) = m￿E1(24) + b [
m 1.56 1.16 to 9.77 S  ]  0.0001 S  (32.1) 0.738
b 5.2 -347 to 17.4 NS 
E1(12) = m￿E1(24) + b [
m 1.11 0.98 to 1.45 NS  ]  0.0002 S  (9.1) 0.951
b 3.0 -10.7 to 7.63 NS 
E1(4) = m￿Tk-GV(4) + b [
m 1.31 1.04 to 1.62 B  ] <0.0001 S  (23.9) 0.928 
a
b 6.5 -8.6 to 18.9 NS 
E1(24) = m￿Tk-GV(24) + b [
m 0.850 0.417 to 0.940 S  ]  0.8386 NS (0.4) 0.948
b 6.0 1.0 to 26.6 B 
E1(2&4) = m￿Tk-GV(24) + b [
m  1.01 0.626 to 1.59 NS  ]  0.0008 S  (20.7) 0.740
b 16.4 -7.0 to 36.0 NS 
Probability Significance ( )
 Paired t-test (  in ml/min)
CI confidenceinterval,R
2 is coefficient of determination, S significant (p<0.01),NS not significant (p>0.05),B borderlinesignificant(0.01<p<0.05)
aNonlinear, 0.05<p<0.1 from cusum. However, R
2 (0.928) and the Spearman rank coefficient squared (0.929) are similar
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2 improves (0.968).
However, the t-test, 3.1 ml/min mean bias, although small, is
still (borderline) significant (p =0 . 0 3 ) .
Significantly poorer results were obtained from the
4-h versus 24-h E1 fitting (see Table 2). Figure 2b shows
these results plotted with a regression slope of 1.56, i.e. the
4-h CL-values are significantly larger than the 24-h CL-
values with a very significant (p = 0.0001) mean difference
of 32.1 ml/min. However, the R
2 value for this plot is 0.738,
whereas the R
2 value (or Spearman rank sum squared, rs
2)
for 4-h CL(Tk-GV) versus CL(E1) data would be signifi-
cantly better, i.e. 0.928 (rs
2=0.929). That the R
2 values of
4- versus 24-h CL(Tk-GV) and 4- versus 24-h CL(E1) are
equal to 3 decimal places (i.e. 0.738), and 4-h CL(Tk-GV)
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Fig. 2 a The Tk-GV plasma clearance method, CL(Tk-GV), was
applied to 4- and 24-h data and plotted. When this is fit with a
Passing-Bablok regression line, there is no significant departure from
unityslopeandnosignificanty-intercept. b The 4-h data CL(E1), plotted
against 24-h CL(E1), has a slope significantly >1, i.e. the 24-h CL(E1)
values are overestimated by 4-h CL(E1) calculations. c CL(Tk-GV) for
12- and 24-h data and no significant departure from a slope of 1 and an
intercept of zero. d Even for 24-h data, CL Tk‐GV ðÞ 6¼ CL E1 ðÞ ,w i t h
both the slope 6¼ 1 and the intercept 6¼ 0 of the Passing-Bablok linear fit
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4-h CL agrees with its corresponding 24-h result (i.e. 0.738)
appears to confirm error propagation as explaining much of
the variance for predicting 24-h CL from 4-h data.
When the sample times included in the fit are increased
to 12 h, then CL(E1-12-h) > CL(E1-24-h) in all cases. The
paired t-test for this is highly significant (p = 0.0002, mean
difference 9.1 ml/min), with an improved R
2 (0.951), (see
Table 2). From the 24-h data (Fig. 1d), the plot of CL(Tk-GV)
versus CL(E1) has a significantly biased slope (0.85) and
borderline significant intercept (5.97 ml/min, 0.01 < p <0 . 0 5 ) .
Note that from Table 2,t h et-test p = 0.8386 mean difference
of 0.4 ml/min is not significant. In other words, on the
average, CL(Tk-GV-24-h) values did not differ from
CL(E1-24-h) values, but, for low CL-values, CL(E1) >
CL(Tk-GV), and for high CL-values, CL(E1) < CL(Tk-GV).
The slope intercept (E1) 2- and 4-h plasma sample
method results follow. The Passing-Bablok regression slope
of CL(E1-2- & 4-h) versus CL(Tk-GV-24-h) has no bias
detected for slope (1.01) and intercept (16.4 ml/min).
However, the intercept is larger than for CL(Tk-GV -4-h)
versus CL(Tk-GV -24-h) (6.7 ml/min). Indeed, paired t testing
(Table 2) shows the mean bias (20.7 ml/min) to be highly
significant (p = 0.0008) for CL(E1-2- & 4-h) versus
CL(Tk-GV -24-h). This compares to the more moderate mean
bias (8.6 ml/min) of borderline significance (p = 0.0337) for
the CL(Tk-GV-4-h) versus CL(Tk-GV-24-h) plot. The
Passing-Bablok regression of CL(E1-24-h) (vertical axis)
versus CL(E1-2- & 4-h) (horizontal axis) has a significantly
lesser slope (p < 0.01) than 1, i.e. 0.65. However, both
CL(E1-24-h) and CL(E1-2- & 4-h) have r-values for fitting
the logarithms of concentrations that are very significantly
poorer (z-statistic t-test p < 0.0001) than CL(Tk-GV-24-h).
Discussion
The Tk-GV models have a less obvious dependence on
sampling-timeeffectsthanE1fits.Theyalsohavelessbiasfor
extrapolation and fit the data very significantly better
(p < 0.0001). Of some concern is that the predictions of
24-h CL from 4-h CL data were imprecise (R
2 = 0.738). This
lower than optimal coefficient of determination is partly due
to a restricted range of CL-values from examining low renal
function patients only, may partly be due to biological
fluctuation of CL in time and is due to the propagation of
errors of measured concentrations, which in turn is due to
errors in sample measurements, e.g. see [2]. In early
prospective clinical experience, CL(Tk-GV) has been imple-
mented for four-sample 4-h
99mTc-DTP A, with some notable
features being that the ease of use, stability of the solutions
and that the error calculations help to improve sampling
technique and inspire confidence in the results. Some of the
sources for error are easily addressed. For example,
extravasation in the injection site is reduced by applying
the flush-bolus technique and checked for by imaging of the
injection site [12]. Whatever the causes for error, use of
Tk-GV has the advantage of increased accuracy for
extrapolated CL (defined as lack of bias) while having
precision (defined as R
2 for CL extrapolation) as good as or
better than that of E1 fitting.
Fractal structures have been postulated as causing a
gamma variate (GV) shape for inert substance CL-curves
[13]. However, it is only when a GV is found using a CL
relative-error minimizing technique that GV (1) accurately
predicts the late-time concentration and (2) consistently
forms a model with a dynamic concentration gradient
established by renal function. The results here suggest that
the 24-h CL(Tk-GV) values are a standard against which to
judge clearance, because of the very good quality of all of
the curve fits (median r = 0.998) (see Fig. 1 and Table 1).
Moreover, prediction of 24-h CL(Tk-GV) from 4- and
12-h CL(Tk-GV) was good, suggesting that 24-h Tk-GV
fits should extrapolate concentration correctly at even later
times. In particular for six statistical tests, CL(Tk-GV)
extrapolation was unbiased for four tests and borderline
biased (i.e. 0.01 < p <0 . 0 5 )f o rt w o ,w h e r e a sCL(E1) was
significantly biased in three of six tests. The 4-h CL(Tk-GV)
versus CL(E1) (Table 2) is somewhat nonlinear (cusum
probability, 0.05 < p <0 . 1[ 7]) and the clinically used slope
intercept method with 2- and 4-h plasma samples differs
from 24-h CL(Tk-GV) by a constant (mean difference
20.7 ml/min, p = 0.0008), so there is no “quick-fix” linear
transformation of CL(E1) values to estimate CL(Tk-GV).
This is discordant with the literature suggesting that
CL(E1-2- & 4-h) may be corrected by multiplying by 0.87,
i.e. the Chantler correction factor, and does not suggest
subtracting a constant [2]. However, it is easy enough to see
how such an impression could arise as the Passing-Bablok
regression of CL(E1-24-h) (vertical axis) versus CL(E1-2- &
4-h) (horizontal axis) only has a significant slope (0.65,
p < 0.01 of slope =1) and an insignificant intercept. However,
both CL(E1-24-h) and CL(E1-2- & 4-h) have r-values for
fitting the logarithms of concentrations that are very
significantly poorer (z-statistic t-test p < 0.0001) than CL
(Tk-GV -24-h). Thus, subtraction of a 16.4 (or 20.7) ml/min
constant from the CL(E1-2- & 4-h) values may be the more
accurate correction, at least for our patients with ascites [and
if one accepts that CL(Tk-GV -24-h) is a gold standard].
A final caveat is that eight of ten patients had ascites.
Ascites has been associated with increased CL for com-
partmental models by 16–20 ml/min [4, 6, 9] and is
considered by some to relatively contraindicate CL testing
due to gross inaccuracy [2]. However, ascites seems to have
had little effect on the CL(Tk-GV)-values here. This is
significant and it needs to be emphasized that the Tk-GV
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This comes about as the Tk-GV volumes of distribution (V)
(and V/W, Table 1) are larger than usual (e.g. see [2]).
However, that is an expected result for ascites (also see [8]),
as follows. For a bolus clearance model, MRT=V/CL,
where MRT is the mean residence time. If in that equation
CL is held constant, then for a longer residence time, V
must be larger, and for a good model, that is an expected
outcome of ascites. V/W is our measure of ascites from the
24-h Tk-GV model. The correlation of r-values from E1
24-h data fits with V/W (Table 1) is significantly negative,
rrE1 ðÞ ;V=W ½  ¼   0:823, p=0.0034. However, the correla-
tion of r-values from 24-h Tk-GV fits to the data
with V/W from the same Tk-GV model is insignificant,
rrTk‐GV ðÞ ;V=W ½  ¼   0:084, p=0.8165. For rrE1 ðÞ ;V=W ½  ,
we have not caused a correlation by reusing parame-
ters, because the only sharing between models is from
the characteristics of the data themselves. For
rrTk‐GV ðÞ ;V=W ½  , we have reused parameters, and
despite this, there is no correlation. We conclude that
using V/W (from 24-h Tk-GV) as an index of the severity
of ascites, E1 fits degrade as ascites increases, and
Tk-GV fit quality is not measurably affected. This
finding confirms the observation that use of E1 (or E1
extrapolation) is problematic in ascites [4, 6, 8, 9]a n d
presents a solution to this problem using Tk-GV . To
inspect this in detail, let us examine the GVrate equation,
1
CðtÞ
dCðtÞ
dt
¼
a−1
t
  b ; ð1Þ
where (a−1)/t is definite negative, is associated with
tissue clearance, and gets slower and slower in time (it is
proportional to 1/t). CL>GFR implies a≤1, where a>1
is a common [8], but ill-posed solution for CL for GV
fitting [13]. Here, using Tk-GV fitting, the entire range of
a for our 24-h data is from 0.62 to 0.88, i.e. a is well
behaved. So a does not change by much to accompany an
increase of fluid volume. Here, a low a=0.67 coincides
with the most inflated volumes of distribution as a
percentage of patient mass 59.9% (case 8, Table 1).
Normally slow or pathologically slow clearance areas in
the body include ascites or abdominal fluid, some adenomas
and neoplasias, some chemotherapy, pleural or pericardial
fluid, lymphatic circulation and lymphoedema, cerebrospinal
fluid circulation, synovial fluid, circulation in aqueous
humour, abscess, cellulitis, fibrous dysplasia, etc. The entire
spectrum of slow tissue marker leakage rates is included in
GVrate Eq. 1 because for all t>(1−a)/", the rates of losses
of marker into tissue are slower than renal loss. That is,
tissue marker leakage rates converging to zero (i.e. to an
infinite half-life) are an integral part of the GV model. By
contrast, an infinite sum of exponential terms would be
needed to approximate the effect of the temporal spectrum of
the single, gradually decreasing rate term of the GV model.
Why only compare Tk-GV to E1 fitting? Why not then
test E2, E3, E4 or En (i.e. sums of exponential terms) in
general? The reason is that a robust model is strongly
desirable, and E(n>1) is not stable for regression analysis
unless the number of samples is substantially greater than n
[10, 13]. Although methods exist for stabilizing E2 models
(e.g. see [11]), in general for regression, En is not robust,
indeed ordinary least-squares GV function fitting is also not
robust. However, GV fitting can be made robust by
regularization (as in Tk-GV [13]). It is at best tedious and
at worst impossible to obtain four (or more) stable
parameter estimates with an unstable E2 (or higher)
regression model. By contrast, a single attempt suffices to
obtain the globally converged Tk-GV model’st h r e e
parameters, with superior quality curve fits, better extrap-
olation to late-time concentrations from fits to early
concentration data and using fewer samples [13]. For
practical measurements, one strongly desires either a simple
robust model (e.g. E1 with correction factors) or another
robust model (e.g. Tk-GV with no need of correction
factors). However, as shown in the results above (Table 2)
the magnitude and the type of the correction factors needed
for E1 CL-values are a function of the times used to obtain
the samples. Even if it were clear how to correct E1 CL-
values (and it is not), any such timing correction formulae
would have empirical coefficients. For example, these
formulae would not apply to both small and large mammals
without allometric rescaling. Moreover, E1 fit quality
degrades in ascites, rendering the utility of the model
questionable. In summary, making “corrections” to an
inherently flawed exponential term model is not optimal.
The better approach using Tk-GV better fits the observed
real-life data, without corrections needed.
Is 24-h a long enough data collection time to determine CL
in renal failure (CL<15 ml/min)? The results suggest that if
we use E1 functions for fitting, the answer would be no. It is
common to plot logarithm concentration versus time, which
would linearize lnC(t)≈−at+b, i.e. an E1 function. In fact,
note in Fig. 1 that C(t) at early times is approximately linear
in lnt, i.e. C(t)≈−alnt+b. This latter plot type helps visually
confirm the correlation results, in that E1 functions have the
wrong shape and do not follow the concentration curves well.
Adding more exponential terms does not solve the curve
shape problem. Let us define late-time C(t) as being after the
concentration curve becomes nonlinear in ln(t), i.e. asymp-
totic to the C(t)=0 axis. Figure 1b demonstrates that when an
exponential fit does not include late-time concentrations, the
late-time concentrations are underestimated. This explains the
overestimation of CL (from underestimation of AUC)f o r( a l l
choices of) E1 early-time extrapolations to later-time fits in
Table 2. However, with the better-fitting Tk-GV functions, the
2254 Eur J Nucl Med Mol Imaging (2011) 38:2247–2256extrapolation errors are not so severe, as suggested by
extrapolation testing of early data. Using Tk-GV for the
lowest CL value (11.4 ml/min, case 10, Fig. 1b), one predicts
that it would take 6 days of data collection for the
concentration to go below 1% of the concentration measured
in the 5-min sample. Adding a “terminal” exponential to the
1-day data collection would underestimate the concentration
at day 6, as exponentials go to zero too quickly to mimic late
concentration. Adding another early exponential term to the
Fig. 1 E1 fits would not remove the exponential fit
assumption of a constant concentration at time zero causing
underestimation of the early concentrations of actual data. On
the other hand, finding the AUC is not especially challenging
when the data collected include all the concentrations that
contribute to them, and any arbitrary interpolative curve
fitting, or numerical integration [5], will suffice for that
purpose. Especially as relates to early-time only data
collections, proper extrapolation is not as arbitrary as
interpolation and must be validated by extrapolation testing,
done here for Tk-GV . Thus, if a 4- or 12-h test is desired for
finding CL, Tk-GV fitting appears to provide an accurate (i.e.
relatively unbiased) method of predicting CL for 24-h, even
in the presence of ascites.
Conclusion
CL(E1) values were dependent on sample time and the quality
of fit was poor and degraded with increasing ascites, consistent
with current opinion that CL(E1) is contraindicated in ascitic
patients. CL(Tk-GV) was relatively more accurate and the
good quality of fit was unaffected by ascites. CL(Tk-GV) was
the preferred method for the accurate calculation of CL and
was useful despite liver failure and ascites.
Conflicts of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix
Tikhonov regularization
For an overdetermined system of linear equations, Ax=b,
the Tikhonov regularization (Tk) of this problem introduces
the penalty function Γx and seeks to find a solution that
minimizes Ax   b kk
2 þ Γx kk
2. This latter is the square of a
norm of the residuals, Ax   b kk
2, plus the square of a norm
of the product of the Tikhonov matrix, Γ,w i t ht h ex fit
parameters (unknowns). The more general Γ
TΓ regularizing
term is often, as it is here, replaced by lI, where I is the
identity matrix, and l is a Lagrange (i.e. constraint)
multiplier, also commonly called the shrinkage, Tikhonov
or damping factor.
A constraint on lnK
A most common constraint for regression is to require
the fit function to pass through the data mean point [aka the
centroid, (x;y)]. Because the logarithm of concentrations is
the more homoscedastic quantity, it is common to fit the
logarithms of marker concentrations rather than the con-
centrations themselves. Thus, for the Tk-GV method, the
GV function is written lnC ¼ lnK þ a   1 ðÞ lnt   bt,
where the constant term lnK need not be independent, but
can be determined from the other fit parameters using a
mean value constraint. Taking averages over the data
lnK ¼ lnCðtÞ  a   1 ðÞ lnt þ bt ¼ b   a   1 ðÞ a1 þ ba2;
ð2Þ
such that b, a1 and a2 are data constants, where b is the
mean value of the logarithms of the concentrations, a1 is
the mean of the logarithms of the sample times and a2 is the
mean of the sample times. Then, Eq. 2 is used to remove K
from the formula for CL, and an expression is derived for
the errors in CL with only a and " as independent
parameters, as follows
CL ¼
D
AUC
¼
Dba
KΓ a ðÞ
¼
Dba
exp b   a   1 ðÞ a1 þ ba2
  
Γ a ðÞ
;
ð3Þ
where the gamma function, ΓðxÞ¼
R 1
0 tx 1e tdt.
Error propagation and the error adaptive equation
One applies error propagation (Taylor series expansion)
to the right-hand CL expression of Eq. 3 with respect to a
and " yielding
sCL
CL
   2
¼ s2
a a1 þ lnb   < a ðÞ ðÞ
2 þ s2
b
a
b
  a2
   2
þ 2sab a1 þ lnb   < a ðÞ ðÞ
a
b
  a2
  
: ð4Þ
where <(a) is the digamma function of α and < a ðÞ ¼
d lnΓ a ðÞ ½  =da ¼ Γ0 a ðÞ =Γ a ðÞ , the subscripted s variables
are the standard deviations of the subscripted quantities and
(sCL/CL)
2 is the squared coefficient of variation CV
2 of CL.
Minimizing the right-hand side of Eq. 4 as a function of the
shrinkage, l, selects a l value that produces the CL value
with the smallest relative error achievable. Also, minimiz-
ing the relative error in CL is indispensable for making
reliable measures of CL when CL is small.
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2,o ft h e
individual volumes of distribution, i.e. (sV/V)
2, is calculat-
ed from the SDs produced from minimizing Eq. 4
substituted into
sV
V
   2
¼ s2
a
1
a
þ a1 þ lnb   < a ðÞ
   2
þ s2
b
a
b
 
1
b
  a2
   2
þ 2sab
1
a
þ a1 þ lnb   < a ðÞ
  
a
b
 
1
b
  a2
  
:
ð5Þ
Equation 5 is from application of the propagation of error
formula to the substitution of Eq. 3 into V=(a/")CL.
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